NCT05907512 2023-06-22Endostar Plus Toripalimab as Adjuvant Therapy for Resectable Stage III-Oligometastatic Stage IV Cutaneous MelanomaFudan UniversityPhase 2 Unknown43 enrolled
NCT03095079 2017-03-29Rh-endostatin in Combination With Dacarbazine and Cisplatin as the First Line Therapy for Metastatic MelanomaPeking University Cancer Hospital & InstitutePhase 2 Unknown70 enrolled